Dual-Peptide Research Formulation

WOLVERINE is a dual-peptide research formulation combining BPC-157 and TB-500 (Thymosin Beta-4 fragment) into a single lyophilized vial. This consolidated format preserves the full 20 mg total peptide content—10 mg BPC-157 and 10 mg TB-500—while enabling investigation of complementary tissue-signaling pathways within a unified research system.

BPC-157 is a gastric-derived pentadecapeptide fragment studied in preclinical research for its involvement in tissue protection, angiogenic signaling, microvascular integrity, and inflammatory pathway modulation. Research frequently examines its relationship to nitric-oxide signaling, epithelial stability, and cytokine balance across a range of experimental models.

TB-500 (Thymosin Beta-4 fragment) is a synthetic peptide corresponding to the active region of the naturally occurring actin-binding protein thymosin beta-4. In laboratory settings, TB-500 is evaluated for its role in cellular migration, cytoskeletal organization, and extracellular matrix (ECM) remodeling, particularly in models focused on tissue repair dynamics.

When combined, BPC-157 and TB-500 present complementary mechanisms of research interest: BPC-157 contributing to vascular stability and inflammatory signaling, and TB-500 supporting actin-mediated cell motility and structural reorganization. This pairing is frequently explored in preclinical research assessing coordinated tissue-repair signaling and potential additive or synergistic pathway interactions.

This formulation is frequently utilized in advanced regenerative research examining vascular support, structural tissue organization, inflammatory balance, and coordinated repair signaling across multiple experimental models.